NovaBay Pharmaceuticals, Inc. Total liabilities

Total liabilities of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total liabilities for the quarter ending June 30, 2022 was $5.8 Million (a -17.72% decrease compared to previous quarter)
  • Year-over-year quarterly Total liabilities increased by 101.7%
  • Annual Total liabilities for 2021 was $13.8 Million (a -61.57% decrease from previous year)
  • Annual Total liabilities for 2020 was $35.9 Million (a 250.59% increase from previous year)
  • Annual Total liabilities for 2019 was $10.2 Million (a 132.52% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total liabilities of NovaBay Pharmaceuticals, Inc.

Most recent Total liabilitiesof NBY including historical data for past 10 years.

Interactive Chart of Total liabilities of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Total liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $5.8 $7.05
2021 $13.81 $2.88 $2.39 $3.09 $13.81
2020 $2.92 $3.2 $12.29 $9.82 $35.93
2019 $10.25 $11.1 $8.2 $8.59 $10.25
2018 $4.41 $4.31 $4.28 $4.95 $4.41
2017 $7.49 $9.22 $8.86 $8.33 $7.49
2016 $8.28 $8.42 $9.47 $12.23 $8.28
2015 $10.18 $6.46 $5.27 $6.01 $10.18
2014 $5.69 $5.35 $4.29 $5.35 $5.69
2013 $7.13 $6.82 $5.62 $5.08 $7.13
2012 $5.19 $6.23 $6.46 $6.67 $5.19
2011 $6.62 $6.62

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology